APA (7th ed.) Citation

Y, L., Q, G., S, L., Z, P., Z, Y., Y, L., . . . X, H. (2025). Corrigendum to Ruxolitinib improves hematopoietic regeneration by restoring mesenchymal stromal cell function in acute graft-versus-host disease. The Journal of clinical investigation, 135(22), . https://doi.org/10.1172/JCI200847

Chicago Style (17th ed.) Citation

Y, Lin, et al. "Corrigendum to Ruxolitinib Improves Hematopoietic Regeneration by Restoring Mesenchymal Stromal Cell Function in Acute Graft-versus-host Disease." The Journal of Clinical Investigation 135, no. 22 (2025). https://doi.org/10.1172/JCI200847.

MLA (9th ed.) Citation

Y, Lin, et al. "Corrigendum to Ruxolitinib Improves Hematopoietic Regeneration by Restoring Mesenchymal Stromal Cell Function in Acute Graft-versus-host Disease." The Journal of Clinical Investigation, vol. 135, no. 22, 2025, https://doi.org/10.1172/JCI200847.